The present invention provides compounds of the following structure;
A-L1-B—C-D
that are useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
The present invention provides compounds of the following structure;
A-L1-B-C-D
that are useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.